FDA managers didn't lash out against staffers who disagreed with the approval of several devices, according to the inspector general for HHS. The investigation resulted from a letter sent by scientists and physicians to the White House in January 2009. The whistleblowers claimed that the agency's process for reviewing potential new medical devices had been "corrupted and distorted by current FDA managers, thereby placing the American people at risk," according to the Wall Street Journal. Report